HC Wainwright & Co. Downgrades Alimera Sciences to Neutral, Maintains $6 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Yi Chen has downgraded Alimera Sciences (NASDAQ:ALIM) from Buy to Neutral while maintaining a $6 price target.

June 25, 2024 | 11:07 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
HC Wainwright & Co. analyst Yi Chen has downgraded Alimera Sciences from Buy to Neutral while maintaining a $6 price target.
The downgrade from Buy to Neutral by a reputable analyst can negatively impact investor sentiment and short-term stock price. However, the maintained price target of $6 suggests that the analyst still sees some value in the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100